Detalles de la búsqueda
1.
Plasma IFN-γ and IL-6 levels correlate with peripheral T-cell numbers but not toxicity in RCC patients treated with CAR T-cells.
Clin Immunol
; 169: 107-113, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27377533
2.
Treatment of metastatic renal cell carcinoma with CAIX CAR-engineered T cells: clinical evaluation and management of on-target toxicity.
Mol Ther
; 21(4): 904-12, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23423337
3.
Long-term stability of T-cell activation and transduction components critical to the processing of clinical batches of gene-engineered T cells.
Cytotherapy
; 15(5): 620-6, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23388583
4.
TCR gene transfer: MAGE-C2/HLA-A2 and MAGE-A3/HLA-DP4 epitopes as melanoma-specific immune targets.
Clin Dev Immunol
; 2012: 586314, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22400038
5.
T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in Patients.
Front Immunol
; 7: 648, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-28082983
Resultados
1 -
5
de 5
1
Próxima >
>>